CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease...
Phase 3
Budapest, Hungary and 223 other locations
capsules (KarX-EC) in participants with agitation associated with Alzheimer's Disease who completed the parent studies CN012-0023 o...
Phase 3
Budapest, Hungary and 162 other locations
female subjects who are aged 55 to 90 years and have mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis rela...
Phase 3
Budapest, Hungary and 130 other locations
The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's...
Phase 3
Budapest, Hungary and 189 other locations
This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.Participants w...
Phase 3
Budapest, Hungary and 344 other locations
safety and tolerability of KarXT in subjects with psychosis associated with Alzheimer's Disease....
Phase 3
Budapest, Hungary and 378 other locations
This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.Participants w...
Phase 3
Budapest, Hungary and 387 other locations
Clinical trials
Research sites
Resources
Legal